OCEAN SCIENCES LTD

ASX:OSSPharmaceuticals, Biotechnology & Life Sciences

284.3M shares on issueASX (delayed) · snapshot 13 Nov 2026388.5M fully diluted+36.6% if every option and right converts$0.012price · delayed$3.1MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 73.2% of what they think they own, once every option and right converts.

Latest raise: Placement, announced 4 Nov 2026, to raise $700k in cash at 1.1c, 21.4% below the last close.

Moderate

Dilution riskprovisional — limited history

Runway 2–4 quarters; options/rights overhang 37% of shares; 1 cash raise in 24 months; since relisting as OSS; prior history under BP8 not included

Absolute levels — not a ranking against other companies.

Cash runway3.0 quarters of funding

Share-count growth (24m)0.0%no issuance filings since 2024; since relisting as OSS; prior history under BP8 not included

Raise cadence (24m)1 cash raiseexcludes announced events with no matching share-issuance (Appendix 2A) filing; since relisting as OSS; prior history under BP8 not included

Options & rights overhang36.6% of shares

In-the-money supply0.0% of shares

Pending proposed issuesopen proposed issue (Appendix 3B)

OCEAN SCIENCES LTD, which changed its ticker from BP8 in September 2026, had 284M ordinary shares on issue as of November 2026, its first share-count filing under the new name. The company has not lodged a new share-issuance (Appendix 2A) filing since January 2024. In the 24-month window, it raised A$700K via a Placement in November 2026, its only capital raise in that period. Options and rights could convert into 104M new shares, a 36.6% overhang, with none in the money and the nearest expiry in December 2026. As of its September 2026 quarter, the company has between 2 and 4 quarters of funding at the recent spend rate. One proposed securities issue is pending with an expected issue date in December 2026.

AI-generated summary of this page's cited filings · updated 12 Nov 2026

Quick answers · 3

Why was OSS in a trading halt?

Ocean Sciences requested a trading halt on 2 Nov 2026, giving the reason "Pending announcement in relation to a material capital raising". Trading was expected to resume 4 Nov 2026.

Is OSS raising capital?

Ocean Sciences has 1 proposed issue of securities pending under Appendix 3B as at 13 Nov 2026; the most recent raise announced is Placement of $700k on 4 Nov 2026.

When do OSS's options expire?

Unexercised options and rights equal 36.6% of Ocean Sciences's shares on issue; the nearest expiry is Dec 2026.

Get told when this changes

Get OSS alerts

Free for up to 2 companies. A daily email when OSS raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.

36.6%

Options & rights overhang

0.0%

In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply

Raises · last 12 months

3.0 qtrs

Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Shown since relisting as OSS (28 Sept 2026); prior history under BP8 is not included. Latest count 284.3M per ASX (delayed) (snapshot 13 Nov 2026).

Cash runway

3.0 qtrs OURS

Two to four quarters of funding at the recent spend rate.

Funds operations to about Aug 2027 at the reported spend rate.

$537k cash after burn.

FILED $72k cash · quarter ended 30 Sept 2026

OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.FILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.

Cash runway history · 1 cash reportUnlock free →

Issuance timeline

Latest 1 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
11 Nov 2026	2A · quoted issue	OSS : ORDINARY FULLY PAID	284.3M	Appendix 2A

Full issuance history · 1 filingUnlock free →

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Securities on issue, by classUnlock free →

Capital raises

1 cash raise in the last 24 months · 1 in the last 12 months · counted since relisting as OSS (28 Sept 2026); prior history under BP8 is not included

$700k

Placement

At 1.1c, 21.4% below the last close

4 Nov 2026 ACTIVE

Full raise history · 4 raisesUnlock free →

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Forward supply calendar · 11 dated eventsUnlock free →

Placement capacity

Shares a company can issue without a holder vote: 15% in any 12 months (Listing Rule 7.1).

No share count from 12 months ago — the 15% is measured against that count, and we hold none.

Placement room leftUnlock free →

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.

Paid plan

1 pending issue on record — Pending issue detail

Size, price, fees, broker and placement-capacity usage for each pending issue.

Unlocks on a paid plan

See plans

Options & convertible securities

36.6%

Options & rights overhang · of current shares

0.0%

In-the-money supply · at current price

104.1M

Potential new shares

Dec 2026

Nearest expiry

What this supply is

Converts when	Securities	% of shares	Price to convert
Price-triggered: share price clears the exercise price	92.1M	32.4%	at least 16.7M states no exercise price
Condition-triggered: a hurdle is met; can lapse	12.0M	4.2%	not the trigger

Exercise price on record: 75.4M priced, 28.7M: no exercise price stated, so never counted in or out of the money. Counts are securities, not shares: a 2A never states what one converts into.

What a price move would switch on

0 in the money at $0.012 today (0.0% of shares); rising to 38.9M at $0.060 (5×, 13.7% of shares).

Priced supply in the money at each of ten sampled prices: the curve.
28.7M (27.6% of supply): no exercise price stated, so never counted in or out of the money. Hatched, not plotted.
14.5M priced above 10× today’s: off this axis, in every total on this page.

Code	Security	Type	Exercise price	Expiry	On issue	Source
OSSAD	Options	Price-triggered	$0.20	11 Dec 2026	13.8M	Filing
OSSAO	Options	Price-triggered	$0.50	28 Feb 2027	10k	Filing
OSSAM	Options	Price-triggered	$0.85	28 Feb 2027	100k	Filing
OSSAN	Options	Price-triggered	$1.00	28 Feb 2027	100k	Filing
OSSO	Options	Price-triggered, no exercise price stated	—	7 July 2027	4.4M	Filing
OSSAJ	Options	Price-triggered	$2.50	1 Nov 2027	500k	Filing
OSSAE	Options	Price-triggered	$0.060	2 Dec 2027	13.6M	Filing
OSSAF	Options	Price-triggered	$0.040	4 Dec 2027	38.9M	Filing
OSSAC	Options	Price-triggered	$0.060	13 Dec 2027	1.8M	Filing
OSSAV	Options	Price-triggered	$0.060	28 Feb 2028	6.7M	Filing
OSSAG	Performance rights	Condition-triggered	—	—	12.0M	Filing Meeting
OSSAA	Options	Price-triggered, no exercise price stated	—	—	12.3M	Filing

Nil: nothing is paid to convert · —: no exercise price stated, or a security type we do not label · Meeting: the notice where terms like these are put to holders · Other companies: options expiry calendar

In-the-money value & price ladder · 12 option linesUnlock free →

Director dealings

Date	Director	Type	Shares	Options	Other	Value	Source
23 Sept 2026	Deepak Jha	Other	—	—	30.0M	—	3Y notice
23 Sept 2026	Francesco Cannavo	Other	105.5M	—	30.0M	—	3Y notice
23 Sept 2026	Matthew Leonard	Other	121.2M	—	30.0M	—	3Y notice